Statistics for Development and preclinical evaluation of theranostic agents targeting muc16/ca125 and nectin-4 expression in breast, ovarian and pancreatic cancers
Total visits
| views | |
|---|---|
| Development and preclinical evaluation of theranostic agents targeting muc16/ca125 and nectin-4 expression in breast, ovarian and pancreatic cancers | 9 |
Total visits per month
| views | |
|---|---|
| October 2024 | 1 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| BABEKER-DISSERTATION-2023.pdf | 107 |
Top country views
| views | |
|---|---|
| Canada | 2 |
Top city views
| views | |
|---|---|
| Regina | 1 |
| Saskatoon | 1 |